Neumora Therapeutics (NMRA) Earnings Date & Reports

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NMRA is expected to report earnings to rise 24.32% to -46 cents per share on May 13

Neumora Therapeutics NMRA Stock Earnings Reports

Q1'25

Est.

$-0.46

Q4'24

Beat

by $0.25

Q3'24

Beat

by $0.20

Q2'24

Beat

by $0.31

Q1'24

Beat

by $0.32

The last earnings report on March 03 showed earnings per share of -37 cents, beating the estimate of -62 cents. With 806.34K shares outstanding, the current market capitalization sits at 216.24M.

View a ticker or compare two or three

Compare

NMRA